Found: 53
Select item for more details and to access through your institution.
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 271, doi. 10.1007/s10637-018-0627-4
- By:
- Publication type:
- Article
Standard Venipuncture vs a Capillary Blood Collection Device for the Prospective Determination of Abnormal Liver Chemistry.
- Published in:
- Journal of Applied Laboratory Medicine, 2023, v. 8, n. 3, p. 535, doi. 10.1093/jalm/jfac127
- By:
- Publication type:
- Article
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
- By:
- Publication type:
- Article
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.845417
- By:
- Publication type:
- Article
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
- By:
- Publication type:
- Article
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
- By:
- Publication type:
- Article
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 5, p. 211, doi. 10.1159/000529919
- By:
- Publication type:
- Article
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16773, doi. 10.3390/ijms242316773
- By:
- Publication type:
- Article
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 1, p. 115, doi. 10.1245/s10434-023-14409-z
- By:
- Publication type:
- Article
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.
- Published in:
- Current Oncology, 2024, v. 31, n. 5, p. 2650, doi. 10.3390/curroncol31050200
- By:
- Publication type:
- Article
Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall Survival.
- Published in:
- Current Oncology, 2023, v. 30, n. 10, p. 9181, doi. 10.3390/curroncol30100663
- By:
- Publication type:
- Article
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?
- Published in:
- Ocular Oncology & Pathology, 2023, v. 9, n. 1/2, p. 25, doi. 10.1159/000529127
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
First-in-human imaging with <sup>89</sup>Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229781
- By:
- Publication type:
- Article
Pharmacokinetic assessment of <sup>18</sup>F-(2S,4R)-4-fluoroglutamine in patients with cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229740
- By:
- Publication type:
- Article
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1825, doi. 10.1634/theoncologist.2020-0521
- By:
- Publication type:
- Article
Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1837, doi. 10.1634/theoncologist.2020-0093
- By:
- Publication type:
- Article
A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.
- Published in:
- Oncologist, 2015, v. 20, n. 7, p. 789, doi. 10.1634/theoncologist.2014-0012
- By:
- Publication type:
- Article
Ipilimumab for Patients With Advanced Mucosal Melanoma.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464
- By:
- Publication type:
- Article
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7453, doi. 10.1002/cam4.3389
- By:
- Publication type:
- Article
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 24, p. 4585, doi. 10.1002/cncr.33870
- By:
- Publication type:
- Article
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 23, p. 4393, doi. 10.1002/cncr.33812
- By:
- Publication type:
- Article
Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4967, doi. 10.1002/cncr.33153
- By:
- Publication type:
- Article
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
- Published in:
- Immunological Reviews, 2005, v. 207, n. 1, p. 242, doi. 10.1111/j.0105-2896.2005.00306.x
- By:
- Publication type:
- Article
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treating advanced hepatocellular carcinoma: How to get out of first gear.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 20, p. 3122, doi. 10.1002/cncr.28850
- By:
- Publication type:
- Article
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 20, p. 3687, doi. 10.1002/cncr.28282
- By:
- Publication type:
- Article
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 11, p. 12272, doi. 10.1002/cam4.5925
- By:
- Publication type:
- Article
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 8, p. 1796, doi. 10.1002/cam4.4579
- By:
- Publication type:
- Article
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3059, doi. 10.1002/cam4.3880
- By:
- Publication type:
- Article
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1800, doi. 10.3390/cancers14071800
- By:
- Publication type:
- Article
Advanced Hepatocellular Cancer: the Current State of Future Research.
- Published in:
- 2016
- By:
- Publication type:
- journal article